Alamar Biosciences Raises $128M in to Accelerate Proteomics Platform
Alamar Biosciences, a leader in precision proteomics for early disease detection raises $100M in Series C round, with an additional $28M...
Source: hitconsultant.net
Fast, Ad-Free News Updates
Stay updated with breaking news from Unmatched Sensitivity. Real-time updates on events, politics, business and more.